AstraZeneca PLC (ZEGA) - Total Liabilities

Latest as of September 2025: €68.48 Billion EUR ≈ $80.07 Billion USD

Based on the latest financial reports, AstraZeneca PLC (ZEGA) has total liabilities worth €68.48 Billion EUR (≈ $80.07 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AstraZeneca PLC long-term investment allocation to see how much of total assets are deployed in long-term investments.

AstraZeneca PLC - Total Liabilities Trend (2014–2024)

This chart illustrates how AstraZeneca PLC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is AstraZeneca PLC's balance sheet.

AstraZeneca PLC Competitors by Total Liabilities

The table below lists competitors of AstraZeneca PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Novartis AG MX:NVSN	Mexico	MX$79.61 Billion
RTX Corporation NYSE:RTX	USA	$105.83 Billion
Roche Holding AG SW:ROG	Switzerland	CHF62.82 Billion
Toyota Motor Corporation ADR NYSE:TM	USA	$62.39 Trillion
Wells Fargo & Company NYSE:WFC	USA	$2.03 Trillion
PetroChina Co Ltd Class A SHG:601857	China	CN¥1.10 Trillion
Roche Holding AG SW:ROP	Switzerland	CHF62.82 Billion
GE Vernova LLC NYSE:GEV	USA	$60.55 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down AstraZeneca PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of AstraZeneca PLC to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AstraZeneca PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AstraZeneca PLC (2014–2024)

The table below shows the annual total liabilities of AstraZeneca PLC from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	€63.16 Billion ≈ $73.85 Billion	+1.95%
2023-12-31	€61.95 Billion ≈ $72.43 Billion	+4.25%
2022-12-31	€59.42 Billion ≈ $69.47 Billion	-10.07%
2021-12-31	€66.08 Billion ≈ $77.25 Billion	+29.33%
2020-12-31	€51.09 Billion ≈ $59.73 Billion	+9.21%
2019-12-31	€46.78 Billion ≈ $54.69 Billion	+0.37%
2018-12-31	€46.61 Billion ≈ $54.49 Billion	-0.22%
2017-12-31	€46.71 Billion ≈ $54.61 Billion	+1.86%
2016-12-31	€45.86 Billion ≈ $53.61 Billion	+10.37%
2015-12-31	€41.55 Billion ≈ $48.57 Billion	+6.67%
2014-12-31	€38.95 Billion ≈ $45.54 Billion	--

About AstraZeneca PLC

F:ZEGA Germany Drug Manufacturers - General

Market Cap

$273.68 Billion

€234.09 Billion EUR

Market Cap Rank

#73 Global

#6 in Germany

Share Price

€75.50

Change (1 day)

-3.82%

52-Week Range

€62.50 - €82.50

All Time High

€82.50